Bärbel (Barb) Rohrer, Ph.D.
Company: MitoChem Therapeutics
Job title: Co-Founder & Chief Scientific Officer
Mitochondrial Protective Therapeutics for Neurodegenerative & Metabolic Diseases 11:30 am
Presenting mitochondrial dysfunction as a hallmark mechanism across rare and challenging diseases Examining the importance of mitochondrial homeostasis in high energy systems – CNS, retina, heart, skeletal muscle, kidney Reviewing a novel small molecule approach to treating mitochondrial dysfunction Analyzing preclinical data in ophthalmic indications of retinitis pigmentosa and dry age-related macular degenerationRead more
day: Day Two